EMD57033

TargetMol
Product Code: TAR-T25372
Supplier: TargetMol
CodeSizePrice
TAR-T25372-1mg1mg£352.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25372-5mg5mg£736.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25372-10mg10mg£978.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25372-25mg25mg£1,348.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25372-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25372-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25372-500mg500mg£4,006.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
EMD57033 is a troponin activator that acts by binding to the cardiac/slow skeletal troponin C isoform and is a dominant Ca2+ sensitizer.
CAS:
147527-31-9
Formula:
C22H23N3O4S
Molecular Weight:
425.5
Pathway:
Membrane transporter/Ion channel|Metabolism
Purity:
0.98
SMILES:
COc1ccc(cc1OC)C(=O)N1CCCc2cc(ccc12)C1=NNC(=O)S[C@@H]1C
Target:
Carbonic Anhydrase|Calcium Channel

References

1. Wang L, Kim K, Parikh S, Cadar AG, Bersell KR, He H, Pinto JR, Kryshtal DO, Knollmann BC. Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes. J Mol Cell Cardiol. 2018 Jan;114:320-327. doi: 10.1016/j.yjmcc.2017.12.002. Epub 2017 Dec 5. PubMed PMID: 29217433; PubMed Central PMCID: PMC5800960. 2. Papadaki M, Vikhorev PG, Marston SB, Messer AE. Uncoupling of myofilament Ca2+ sensitivity from troponin I phosphorylation by mutations can be reversed by epigallocatechin-3-gallate. Cardiovasc Res. 2015 Oct 1;108(1):99-110. doi: 10.1093/cvr/cvv181. Epub 2015 Jun 24. PubMed PMID: 26109583; PubMed Central PMCID: PMC4905512. 3. ?rstavik ?, Manfra O, Andressen KW, Andersen G?, Skomedal T, Osnes JB, Levy FO, Krobert KA. The inotropic effect of the active metabolite of levosimendan, OR-1896, is mediated through inhibition of PDE3 in rat ventricular myocardium. PLoS One. 2015 Mar 4;10(3):e0115547. doi: 10.1371/journal.pone.0115547. eCollection 2015. PubMed PMID: 25738589; PubMed Central PMCID: PMC4349697. 4. Vikhorev PG, Song W, Wilkinson R, Copeland O, Messer AE, Ferenczi MA, Marston SB. The dilated cardiomyopathy-causing mutation ACTC E361G in cardiac muscle myofibrils specifically abolishes modulation of Ca(2+) regulation by phosphorylation of troponin I. Biophys J. 2014 Nov 18;107(10):2369-80. doi: 10.1016/j.bpj.2014.10.024. PubMed PMID: 25418306; PubMed Central PMCID: PMC4241448.